Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management by Gregory A. BroderickOral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management by Gregory A. Broderick

Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical Management

EditorGregory A. Broderick

Paperback | December 9, 2010

Pricing and Purchase Info

$222.54 online 
$232.95 list price
Earn 1,113 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


A state-of-the-art review of each aspect of male sexual dysfunction (interest, performance, and orgasm) and their implications for treatment. The authors address a wide variety of clinical issues, ranging from common medical risk factors for ED, to the evaluation and management of men who have atypical presentations that require focused testing; from diabetic ED to the safety assessment of PDE inhibitors for cardiac patients; and from combination drug therapy for refractory patients to neuropharmacological therapies. On the pharmaceutical side, the authors summarize the pharmacology and development of PDE-type 5 inhibitors, review the preclinical data and 5 years of postmarketing data on Viagra®, examine the preclinical data on Levitra®, and discuss the design and conduct of US clinical trials of Cialis®. Oral Pharmacology for Male Sexual Dysfunction: A Guide to Clinical Management clarifies for urologists, family physicians, and internists each of the diagnostic approaches to male sexual dysfunction, as well as the pharmacological strategies available for its safe and effective management.
Title:Oral Pharmacotherapy for Male Sexual Dysfunction: A Guide to Clinical ManagementFormat:PaperbackDimensions:464 pages, 9.02 × 5.98 × 0.01 inPublished:December 9, 2010Publisher:Humana PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617375780

ISBN - 13:9781617375781

Look for similar items by category:


Table of Contents

Physiology and Pharmacology of Erectile DysfunctionRafael Carrion, Derek Bochinski, Nadeem Rahman, and Tom F. LueEpidemiology of Erectile DysfunctionJonathan D. Schiff and John P. MulhallPharmacology of Phosphodiesterase InhibitorsErwin BischoffSildenafil Citrate, the Classical PDE5 Inhibitor: A Five-Year Review of its Efficacy and Safety in the Arena of Erectile DysfunctionHarin Padma-NathanTadalafil: Clinical Trials ExperienceCulley C. Carson, IIIVardenafil: Clinical Trials ExperienceAjay NehraErectile Dysfunction Assessment and Management in Primary Care PracticeLouis Kuritzky and Martin MinerWhen to Refer the Patient With Erectile Dysfunction to a SpecialistIra D. SharlipErectile Dysfunction: Assessing Risk and Managing the Cardiac PatientThorsten Reffelmann and Robert A. KlonerIs Diabetic Erectile Dysfunction More Difficult to Treat?Pierre Theuma and Vivian A. FonsecaDepression and Antidepressant-Associated Erectile DysfunctionRaymond C. RosenIntracavernous, Transurethral, and Topical Therapies for Erectile Dysfunction in the Era of Oral Pharmacotherapy: Salvaging First-Line Therapy Failures With Combination TherapiesHans-Martin A. Fritsche, Mustafa F. Usta, and Wayne J. G. HellstromAndrogen Deficiency of the Aging Male: Enhancing Erectile Response to Oral PharmacotherapyAlvaro Morales and Jeremy P. W. HeatonCentral Activation of Erection and Clinical ExperienceJeremy P. W. Heaton, Alvaro Morales, and Michael A. AdamsSustaining the Cure: Oral Pharmacotherapy Failures Salvag With Vacuum Devices and Penile ImplantsRonald W. LewisPrevention and Treatment of Erectile Dysfunction Utilizing Lifestyle Changes and Dietary Supplements: What Works and What is Worthless?Mark A. MoyadPharmacological Strategies in the Management of Rapid EjaculationChris G. McMahonSexual Dysfunction After Radical Prostatectomy and the Use of PDE-5 InhibitorsAndrew McCulloughFemale Sexual Dysfunction: Is There a Magic Pill?Ridwan Shabsigh, Anne R. Davis, Aristotelis G. Anastasiadis, Nawras Makhsida, and Grace YanIndex